Skip to main content
PMC home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1996 Oct;117(2):343–348. doi: 10.1017/s0950268800001527

Seroepidemiology of HTLV-I in relation to that of HIV-1 in the Gauteng region, South Africa, using dried blood spots on filter papers.

M B Taylor 1, S P Parker 1, H H Crewe-Brown 1, J McIntyre 1, W D Cubitt 1
PMCID: PMC2271693  PMID: 8870632

Abstract

The seroprevalence of human T-lymphotropic virus type I (HTLV-I), in relation to that of human immunodeficiency virus type I (HIV-1), was determined in a comparative unlinked anonymous antenatal and neonatal (for indirect measurement of maternal antibodies) serosurvey in the Gauteng region of South Africa, using dried blood spots (DBS) and modified particle agglutination assays. Samples were confirmed to be antibody positive by western blot. A total of 2582 DBS collected during 1993 and 1994 from subjects of African, European and coloured origin were tested. Ten were confirmed as positive for HTLV-I and 128 for HIV-1. No antibodies to HTLV-I or HIV-1 were demonstrated in the 221 women of European and coloured origin who were screened. The HTLV-I seroprevalence rate in subjects of African origin appeared to increase from 0% in 1993 to 0.49% in 1994, while HIV-1 seroprevalence rates of 5.2% and 5.4% were recorded for 1993 and 1994 respectively. No significant differences in HTLV-I and HIV-1 seroprevalence rates were noted for the two areas investigated. These results indicate that HTLV-I should be included in infection control programs, and provide baseline data for monitoring the possible spread of HTLV-I in the heterosexual population in this region.

Full text

PDF
343

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades A. E., Parker S., Berry T., Holland F. J., Davison C. F., Cubitt D., Hjelm M., Wilcox A. H., Hudson C. N., Briggs M. Prevalence of maternal HIV-1 infection in Thames regions: results from anonymous unlinked neonatal testing. Lancet. 1991 Jun 29;337(8757):1562–1565. doi: 10.1016/0140-6736(91)93260-g. [DOI] [PubMed] [Google Scholar]
  2. Becker W. B., Becker M. L., Homma T., Brede H. D., Kurth R. Serum antibodies to human T-cell leukaemia virus type I in different ethnic groups and in non-human primates in South Africa. S Afr Med J. 1985 Mar 23;67(12):445–449. [PubMed] [Google Scholar]
  3. Becker W. B., Botha M. C., Engelbrecht S., Becker M. L. Isolation of human T-lymphotropic virus type I (HTLV-I) from a black South African with Kaposi's sarcoma. S Afr Med J. 1988 Apr 16;73(8):481–483. [PubMed] [Google Scholar]
  4. Bhigjee A. I., Kelbe C., Haribhai H. C., Windsor I. M., Hoffmann M. H., Modi G., Bill P. L., Becker W. B., Singh B., Engelbrecht S. Myelopathy associated with human T cell lymphotropic virus type I (HTLV-I) in natal, South Africa. A clinical and investigative study in 24 patients. Brain. 1990 Oct;113(Pt 5):1307–1320. doi: 10.1093/brain/113.5.1307. [DOI] [PubMed] [Google Scholar]
  5. Bhigjee A. I., Thaler D., Madurai S., Gouws E., Bill P. L. Seroprevalence of HTLV-I in Natal/KwaZulu. S Afr Med J. 1994 Jun;84(6):368–368. [PubMed] [Google Scholar]
  6. Bhigjee A. I., Vinsen C., Windsor I. M., Gouws E., Bill P. L., Tait D. Prevalence and transmission of HTLV-I infection in Natal/KwaZulu. S Afr Med J. 1993 Sep;83(9):665–667. [PubMed] [Google Scholar]
  7. Blattner W. A., Kalyanaraman V. S., Robert-Guroff M., Lister T. A., Galton D. A., Sarin P. S., Crawford M. H., Catovsky D., Greaves M., Gallo R. C. The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer. 1982 Sep 15;30(3):257–264. doi: 10.1002/ijc.2910300302. [DOI] [PubMed] [Google Scholar]
  8. Blayney D. W., Blattner W. A., Robert-Guroff M., Jaffe E. S., Fisher R. I., Bunn P. A., Jr, Patton M. G., Rarick H. R., Gallo R. C. The human T-cell leukemia-lymphoma virus in the southeastern United States. JAMA. 1983 Aug 26;250(8):1048–1052. [PubMed] [Google Scholar]
  9. Botha M. C., Jones M., de Klerk W. A., Yamamoto N. Distribution and possible spread of human T-cell leukaemia virus type I in human communities in the northern and eastern Transvaal. S Afr Med J. 1985 Apr 27;67(17):668–671. [PubMed] [Google Scholar]
  10. D'Ambra M. N., Risk S. C. Aprotinin, erythropoietin, and blood substitutes. Int Anesthesiol Clin. 1990 Fall;28(4):237–240. [PubMed] [Google Scholar]
  11. Garin B., Gosselin S., de Thé G., Gessain A. HTLV-I/II infection in a high viral endemic area of Zaire, Central Africa: comparative evaluation of serology, PCR, and significance of indeterminate western blot pattern. J Med Virol. 1994 Sep;44(1):104–109. doi: 10.1002/jmv.1890440119. [DOI] [PubMed] [Google Scholar]
  12. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
  13. Goubau P., Desmyter J., Swanson P., Reynders M., Shih J., Surmont I., Kazadi K., Lee H. Detection of HTLV-I and HTLV-II infection in Africans using type-specific envelope peptides. J Med Virol. 1993 Jan;39(1):28–32. doi: 10.1002/jmv.1890390107. [DOI] [PubMed] [Google Scholar]
  14. Greaves M. F., Verbi W., Tilley R., Lister T. A., Habeshaw J., Guo H. G., Trainor C. D., Robert-Guroff M., Blattner W., Reitz M. Human T-cell leukemia virus (HTLV) in the United Kingdom. Int J Cancer. 1984 Jun 15;33(6):795–806. doi: 10.1002/ijc.2910330614. [DOI] [PubMed] [Google Scholar]
  15. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K. I., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476–6480. doi: 10.1073/pnas.78.10.6476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jogessar V. B., de Bruyn C. C., Bhigjee A. I., Naicker V. L., Bill P. L., Tait D. Adult T-cell leukaemia/lymphoma associated with HTLV-I in Natal. S Afr Med J. 1992 May 16;81(10):528–529. [PubMed] [Google Scholar]
  17. Joubert J., van As A. D., Lecatsas G., Bos P. Human T-lymphotropic virus type I-associated myelopathy. A case report. S Afr Med J. 1991 Dec 7;80(11-12):592–593. [PubMed] [Google Scholar]
  18. LaGrenade L., Hanchard B., Fletcher V., Cranston B., Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet. 1990 Dec 1;336(8727):1345–1347. doi: 10.1016/0140-6736(90)92896-p. [DOI] [PubMed] [Google Scholar]
  19. Lecatsas G., Joubert J. J., Schutte C. H., Taylor M. B., Swanevelder C. HTLV-I seropositivity in east Caprivi, SWA/Namibia. S Afr Med J. 1988 Dec 17;74(12):643–644. [PubMed] [Google Scholar]
  20. Mochizuki M., Watanabe T., Yamaguchi K., Takatsuki K., Yoshimura K., Shirao M., Nakashima S., Mori S., Araki S., Miyata N. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res. 1992 Mar;83(3):236–239. doi: 10.1111/j.1349-7006.1992.tb00092.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Neill A. G., Fernandes-Costa F. J. Anti-HTLV-I in blood donors in Natal. S Afr Med J. 1990 Sep 15;78(6):376–376. [PubMed] [Google Scholar]
  22. Nightingale S., Orton D., Ratcliffe D., Skidmore S., Tosswill J., Desselberger U. Antenatal survey for the seroprevalence of HTLV-1 infections in the West Midlands, England. Epidemiol Infect. 1993 Apr;110(2):379–387. doi: 10.1017/s0950268800068321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Noda S., Eizuru Y., Minamishima Y., Ikenoue T., Mori N. Detection of human T-cell lymphotropic virus type 1 infection by the polymerase chain reaction using dried blood specimens on filter papers. J Virol Methods. 1993 Jun;43(1):111–122. doi: 10.1016/0166-0934(93)90094-8. [DOI] [PubMed] [Google Scholar]
  24. Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H., Tara M., Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol. 1987 Feb;21(2):117–122. doi: 10.1002/ana.410210203. [DOI] [PubMed] [Google Scholar]
  25. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986 May 3;1(8488):1031–1032. doi: 10.1016/s0140-6736(86)91298-5. [DOI] [PubMed] [Google Scholar]
  26. Parker S. P., Taylor M. B., Ades A. E., Cubitt W. D., Peckham C. Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes. J Clin Pathol. 1995 Oct;48(10):904–907. doi: 10.1136/jcp.48.10.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Peckham C. S., Tedder R. S., Briggs M., Ades A. E., Hjelm M., Wilcox A. H., Parra-Mejia N., O'Connor C. Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet. 1990 Mar 3;335(8688):516–519. doi: 10.1016/0140-6736(90)90746-r. [DOI] [PubMed] [Google Scholar]
  28. Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer. 1990 Feb 15;45(2):237–243. doi: 10.1002/ijc.2910450206. [DOI] [PubMed] [Google Scholar]
  29. Taylor M. B., Janse van Rensburg E., Swanevelder C., Carlier N. D., Glatthaar E. HIV and HTLV-I survey in Venda. S Afr Med J. 1992 May 2;81(9):485–485. [PubMed] [Google Scholar]
  30. Yamaguchi K. Human T-lymphotropic virus type I in Japan. Lancet. 1994 Jan 22;343(8891):213–216. doi: 10.1016/s0140-6736(94)90994-6. [DOI] [PubMed] [Google Scholar]
  31. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031–2035. doi: 10.1073/pnas.79.6.2031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yourno J. Direct polymerase chain reaction for detection of human immunodeficiency virus in blood spot residues on filter paper after elution of antibodies: an adjunct to serological surveys for estimating vertical transmission rates among human immunodeficiency virus antibody-positive newborns. J Clin Microbiol. 1993 May;31(5):1364–1367. doi: 10.1128/jcm.31.5.1364-1367.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. de-Thé G., Gessain A., Gazzolo L., Robert-Guroff M., Najberg G., Calender A., Peti M., Brubaker G., Bensliman A., Fabry F. Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries. Cancer Res. 1985 Sep;45(9 Suppl):4633s–4636s. [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES